1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global CNS Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Neurodegenerative Diseases 1.2.3 Mood Disorders 1.2.4 Schizophrenia 1.2.5 Autism 1.2.6 Depression 1.3 Market by Application 1.3.1 Global CNS Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Use 1.3.3 Clinic Use 1.3.4 Household 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global CNS Therapeutics Market Perspective (2016-2027) 2.2 CNS Therapeutics Growth Trends by Regions 2.2.1 CNS Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 CNS Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 CNS Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 CNS Therapeutics Industry Dynamic 2.3.1 CNS Therapeutics Market Trends 2.3.2 CNS Therapeutics Market Drivers 2.3.3 CNS Therapeutics Market Challenges 2.3.4 CNS Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top CNS Therapeutics Players by Revenue 3.1.1 Global Top CNS Therapeutics Players by Revenue (2016-2021) 3.1.2 Global CNS Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global CNS Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by CNS Therapeutics Revenue 3.4 Global CNS Therapeutics Market Concentration Ratio 3.4.1 Global CNS Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by CNS Therapeutics Revenue in 2020 3.5 CNS Therapeutics Key Players Head office and Area Served 3.6 Key Players CNS Therapeutics Product Solution and Service 3.7 Date of Enter into CNS Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 CNS Therapeutics Breakdown Data by Type 4.1 Global CNS Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global CNS Therapeutics Forecasted Market Size by Type (2022-2027) 5 CNS Therapeutics Breakdown Data by Application 5.1 Global CNS Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global CNS Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America CNS Therapeutics Market Size (2016-2027) 6.2 North America CNS Therapeutics Market Size by Type 6.2.1 North America CNS Therapeutics Market Size by Type (2016-2021) 6.2.2 North America CNS Therapeutics Market Size by Type (2022-2027) 6.2.3 North America CNS Therapeutics Market Size by Type (2016-2027) 6.3 North America CNS Therapeutics Market Size by Application 6.3.1 North America CNS Therapeutics Market Size by Application (2016-2021) 6.3.2 North America CNS Therapeutics Market Size by Application (2022-2027) 6.3.3 North America CNS Therapeutics Market Size by Application (2016-2027) 6.4 North America CNS Therapeutics Market Size by Country 6.4.1 North America CNS Therapeutics Market Size by Country (2016-2021) 6.4.2 North America CNS Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe CNS Therapeutics Market Size (2016-2027) 7.2 Europe CNS Therapeutics Market Size by Type 7.2.1 Europe CNS Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe CNS Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe CNS Therapeutics Market Size by Type (2016-2027) 7.3 Europe CNS Therapeutics Market Size by Application 7.3.1 Europe CNS Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe CNS Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe CNS Therapeutics Market Size by Application (2016-2027) 7.4 Europe CNS Therapeutics Market Size by Country 7.4.1 Europe CNS Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe CNS Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific CNS Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific CNS Therapeutics Market Size by Type 8.2.1 Asia-Pacific CNS Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific CNS Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific CNS Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific CNS Therapeutics Market Size by Application 8.3.1 Asia-Pacific CNS Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific CNS Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific CNS Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific CNS Therapeutics Market Size by Region 8.4.1 Asia-Pacific CNS Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific CNS Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America CNS Therapeutics Market Size (2016-2027) 9.2 Latin America CNS Therapeutics Market Size by Type 9.2.1 Latin America CNS Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America CNS Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America CNS Therapeutics Market Size by Type (2016-2027) 9.3 Latin America CNS Therapeutics Market Size by Application 9.3.1 Latin America CNS Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America CNS Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America CNS Therapeutics Market Size by Application (2016-2027) 9.4 Latin America CNS Therapeutics Market Size by Country 9.4.1 Latin America CNS Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America CNS Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa CNS Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa CNS Therapeutics Market Size by Type 10.2.1 Middle East & Africa CNS Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa CNS Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa CNS Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa CNS Therapeutics Market Size by Application 10.3.1 Middle East & Africa CNS Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa CNS Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa CNS Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa CNS Therapeutics Market Size by Country 10.4.1 Middle East & Africa CNS Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa CNS Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer CNS Therapeutics Introduction 11.1.4 Pfizer Revenue in CNS Therapeutics Business (2016-2021) 11.1.5 Pfizer Recent Development 11.2 Janssen Pharmaceuticals 11.2.1 Janssen Pharmaceuticals Company Details 11.2.2 Janssen Pharmaceuticals Business Overview 11.2.3 Janssen Pharmaceuticals CNS Therapeutics Introduction 11.2.4 Janssen Pharmaceuticals Revenue in CNS Therapeutics Business (2016-2021) 11.2.5 Janssen Pharmaceuticals Recent Development 11.3 Allergan 11.3.1 Allergan Company Details 11.3.2 Allergan Business Overview 11.3.3 Allergan CNS Therapeutics Introduction 11.3.4 Allergan Revenue in CNS Therapeutics Business (2016-2021) 11.3.5 Allergan Recent Development 11.4 Lundbeck 11.4.1 Lundbeck Company Details 11.4.2 Lundbeck Business Overview 11.4.3 Lundbeck CNS Therapeutics Introduction 11.4.4 Lundbeck Revenue in CNS Therapeutics Business (2016-2021) 11.4.5 Lundbeck Recent Development 11.5 Teva 11.5.1 Teva Company Details 11.5.2 Teva Business Overview 11.5.3 Teva CNS Therapeutics Introduction 11.5.4 Teva Revenue in CNS Therapeutics Business (2016-2021) 11.5.5 Teva Recent Development 11.6 Camber Pharmaceuticals 11.6.1 Camber Pharmaceuticals Company Details 11.6.2 Camber Pharmaceuticals Business Overview 11.6.3 Camber Pharmaceuticals CNS Therapeutics Introduction 11.6.4 Camber Pharmaceuticals Revenue in CNS Therapeutics Business (2016-2021) 11.6.5 Camber Pharmaceuticals Recent Development 11.7 Zhejiang Haisen Pharmaceutical 11.7.1 Zhejiang Haisen Pharmaceutical Company Details 11.7.2 Zhejiang Haisen Pharmaceutical Business Overview 11.7.3 Zhejiang Haisen Pharmaceutical CNS Therapeutics Introduction 11.7.4 Zhejiang Haisen Pharmaceutical Revenue in CNS Therapeutics Business (2016-2021) 11.7.5 Zhejiang Haisen Pharmaceutical Recent Development 11.8 Jewim Pharmaceutical 11.8.1 Jewim Pharmaceutical Company Details 11.8.2 Jewim Pharmaceutical Business Overview 11.8.3 Jewim Pharmaceutical CNS Therapeutics Introduction 11.8.4 Jewim Pharmaceutical Revenue in CNS Therapeutics Business (2016-2021) 11.8.5 Jewim Pharmaceutical Recent Development 11.9 Cipla 11.9.1 Cipla Company Details 11.9.2 Cipla Business Overview 11.9.3 Cipla CNS Therapeutics Introduction 11.9.4 Cipla Revenue in CNS Therapeutics Business (2016-2021) 11.9.5 Cipla Recent Development 11.10 Merck Sharp & Dohme Corp. 11.10.1 Merck Sharp & Dohme Corp. Company Details 11.10.2 Merck Sharp & Dohme Corp. Business Overview 11.10.3 Merck Sharp & Dohme Corp. CNS Therapeutics Introduction 11.10.4 Merck Sharp & Dohme Corp. Revenue in CNS Therapeutics Business (2016-2021) 11.10.5 Merck Sharp & Dohme Corp. Recent Development 11.11 Eli Lilly 11.11.1 Eli Lilly Company Details 11.11.2 Eli Lilly Business Overview 11.11.3 Eli Lilly CNS Therapeutics Introduction 11.11.4 Eli Lilly Revenue in CNS Therapeutics Business (2016-2021) 11.11.5 Eli Lilly Recent Development 11.12 GlaxoSmithKline 11.12.1 GlaxoSmithKline Company Details 11.12.2 GlaxoSmithKline Business Overview 11.12.3 GlaxoSmithKline CNS Therapeutics Introduction 11.12.4 GlaxoSmithKline Revenue in CNS Therapeutics Business (2016-2021) 11.12.5 GlaxoSmithKline Recent Development 11.13 Novartis 11.13.1 Novartis Company Details 11.13.2 Novartis Business Overview 11.13.3 Novartis CNS Therapeutics Introduction 11.13.4 Novartis Revenue in CNS Therapeutics Business (2016-2021) 11.13.5 Novartis Recent Development 11.14 LUPIN 11.14.1 LUPIN Company Details 11.14.2 LUPIN Business Overview 11.14.3 LUPIN CNS Therapeutics Introduction 11.14.4 LUPIN Revenue in CNS Therapeutics Business (2016-2021) 11.14.5 LUPIN Recent Development 11.15 ZYDUS PHARMS 11.15.1 ZYDUS PHARMS Company Details 11.15.2 ZYDUS PHARMS Business Overview 11.15.3 ZYDUS PHARMS CNS Therapeutics Introduction 11.15.4 ZYDUS PHARMS Revenue in CNS Therapeutics Business (2016-2021) 11.15.5 ZYDUS PHARMS Recent Development 11.16 Biogen 11.16.1 Biogen Company Details 11.16.2 Biogen Business Overview 11.16.3 Biogen CNS Therapeutics Introduction 11.16.4 Biogen Revenue in CNS Therapeutics Business (2016-2021) 11.16.5 Biogen Recent Development 11.17 Otsuka Pharmaceutical 11.17.1 Otsuka Pharmaceutical Company Details 11.17.2 Otsuka Pharmaceutical Business Overview 11.17.3 Otsuka Pharmaceutical CNS Therapeutics Introduction 11.17.4 Otsuka Pharmaceutical Revenue in CNS Therapeutics Business (2016-2021) 11.17.5 Otsuka Pharmaceutical Recent Development 11.18 Astra Zeneca 11.18.1 Astra Zeneca Company Details 11.18.2 Astra Zeneca Business Overview 11.18.3 Astra Zeneca CNS Therapeutics Introduction 11.18.4 Astra Zeneca Revenue in CNS Therapeutics Business (2016-2021) 11.18.5 Astra Zeneca Recent Development 11.18 Takeda .1 Takeda Company Details .2 Takeda Business Overview .3 Takeda CNS Therapeutics Introduction .4 Takeda Revenue in CNS Therapeutics Business (2016-2021) .5 Takeda Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global CNS Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Neurodegenerative Diseases Table 3. Key Players of Mood Disorders Table 4. Key Players of Schizophrenia Table 5. Key Players of Autism Table 6. Key Players of Depression Table 7. Global CNS Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global CNS Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global CNS Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global CNS Therapeutics Market Share by Regions (2016-2021) Table 11. Global CNS Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global CNS Therapeutics Market Share by Regions (2022-2027) Table 13. CNS Therapeutics Market Trends Table 14. CNS Therapeutics Market Drivers Table 15. CNS Therapeutics Market Challenges Table 16. CNS Therapeutics Market Restraints Table 17. Global CNS Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 18. Global CNS Therapeutics Market Share by Players (2016-2021) Table 19. Global Top CNS Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CNS Therapeutics as of 2020) Table 20. Ranking of Global Top CNS Therapeutics Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by CNS Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players CNS Therapeutics Product Solution and Service Table 24. Date of Enter into CNS Therapeutics Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global CNS Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 27. Global CNS Therapeutics Revenue Market Share by Type (2016-2021) Table 28. Global CNS Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global CNS Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global CNS Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global CNS Therapeutics Revenue Market Share by Application (2016-2021) Table 32. Global CNS Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global CNS Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America CNS Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 35. North America CNS Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 36. North America CNS Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 37. North America CNS Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 38. North America CNS Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 39. North America CNS Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe CNS Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 41. Europe CNS Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe CNS Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 43. Europe CNS Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe CNS Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe CNS Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific CNS Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific CNS Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific CNS Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific CNS Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific CNS Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific CNS Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America CNS Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America CNS Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America CNS Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America CNS Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America CNS Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America CNS Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa CNS Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa CNS Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa CNS Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa CNS Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa CNS Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa CNS Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 64. Pfizer Company Details Table 65. Pfizer Business Overview Table 66. Pfizer CNS Therapeutics Product Table 67. Pfizer Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million) Table 68. Pfizer Recent Development Table 69. Janssen Pharmaceuticals Company Details Table 70. Janssen Pharmaceuticals Business Overview Table 71. Janssen Pharmaceuticals CNS Therapeutics Product Table 72. Janssen Pharmaceuticals Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million) Table 73. Janssen Pharmaceuticals Recent Development Table 74. Allergan Company Details Table 75. Allergan Business Overview Table 76. Allergan CNS Therapeutics Product Table 77. Allergan Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million) Table 78. Allergan Recent Development Table 79. Lundbeck Company Details Table 80. Lundbeck Business Overview Table 81. Lundbeck CNS Therapeutics Product Table 82. Lundbeck Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million) Table 83. Lundbeck Recent Development Table 84. Teva Company Details Table 85. Teva Business Overview Table 86. Teva CNS Therapeutics Product Table 87. Teva Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million) Table 88. Teva Recent Development Table 89. Camber Pharmaceuticals Company Details Table 90. Camber Pharmaceuticals Business Overview Table 91. Camber Pharmaceuticals CNS Therapeutics Product Table 92. Camber Pharmaceuticals Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million) Table 93. Camber Pharmaceuticals Recent Development Table 94. Zhejiang Haisen Pharmaceutical Company Details Table 95. Zhejiang Haisen Pharmaceutical Business Overview Table 96. Zhejiang Haisen Pharmaceutical CNS Therapeutics Product Table 97. Zhejiang Haisen Pharmaceutical Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million) Table 98. Zhejiang Haisen Pharmaceutical Recent Development Table 99. Jewim Pharmaceutical Company Details Table 100. Jewim Pharmaceutical Business Overview Table 101. Jewim Pharmaceutical Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million) Table 102. Jewim Pharmaceutical Recent Development Table 103. Cipla Company Details Table 104. Cipla Business Overview Table 105. Cipla CNS Therapeutics Product Table 106. Cipla Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million) Table 107. Cipla Recent Development Table 108. Merck Sharp & Dohme Corp. Company Details Table 109. Merck Sharp & Dohme Corp. Business Overview Table 110. Merck Sharp & Dohme Corp. CNS Therapeutics Product Table 111. Merck Sharp & Dohme Corp. Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million) Table 112. Merck Sharp & Dohme Corp. Recent Development Table 113. Eli Lilly Company Details Table 114. Eli Lilly Business Overview Table 115. Eli Lilly CNS Therapeutics Product Table 116. Eli Lilly Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million) Table 117. Eli Lilly Recent Development Table 118. GlaxoSmithKline Company Details Table 119. GlaxoSmithKline Business Overview Table 120. GlaxoSmithKline CNS Therapeutics Product Table 121. GlaxoSmithKline Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million) Table 122. GlaxoSmithKline Recent Development Table 123. Novartis Company Details Table 124. Novartis Business Overview Table 125. Novartis CNS Therapeutics Product Table 126. Novartis Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million) Table 127. Novartis Recent Development Table 128. LUPIN Company Details Table 129. LUPIN Business Overview Table 130. LUPIN CNS Therapeutics Product Table 131. LUPIN Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million) Table 132. LUPIN Recent Development Table 133. ZYDUS PHARMS Company Details Table 134. ZYDUS PHARMS Business Overview Table 135. ZYDUS PHARMS CNS Therapeutics Product Table 136. ZYDUS PHARMS Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million) Table 137. ZYDUS PHARMS Recent Development Table 138. Biogen Company Details Table 139. Biogen Business Overview Table 140. Biogen CNS Therapeutics Product Table 141. Biogen Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million) Table 142. Biogen Recent Development Table 143. Otsuka Pharmaceutical Company Details Table 144. Otsuka Pharmaceutical Business Overview Table 145. Otsuka Pharmaceutical CNS Therapeutics Product Table 146. Otsuka Pharmaceutical Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million) Table 147. Otsuka Pharmaceutical Recent Development Table 148. Astra Zeneca Company Details Table 149. Astra Zeneca Business Overview Table 150. Astra Zeneca CNS Therapeutics Product Table 151. Astra Zeneca Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million) Table 152. Astra Zeneca Recent Development Table 153. Takeda Company Details Table 154. Takeda Business Overview Table 155. Takeda CNS Therapeutics Product Table 156. Takeda Revenue in CNS Therapeutics Business (2016-2021) & (US$ Million) Table 157. Takeda Recent Development Table 158. Research Programs/Design for This Report Table 159. Key Data Information from Secondary Sources Table 160. Key Data Information from Primary Sources List of Figures Figure 1. Global CNS Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Neurodegenerative Diseases Features Figure 3. Mood Disorders Features Figure 4. Schizophrenia Features Figure 5. Autism Features Figure 6. Depression Features Figure 7. Global CNS Therapeutics Market Share by Application: 2020 VS 2027 Figure 8. Hospital Use Case Studies Figure 9. Clinic Use Case Studies Figure 10. Household Case Studies Figure 11. Other Case Studies Figure 12. CNS Therapeutics Report Years Considered Figure 13. Global CNS Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 14. Global CNS Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global CNS Therapeutics Market Share by Regions: 2020 VS 2027 Figure 16. Global CNS Therapeutics Market Share by Regions (2022-2027) Figure 17. Global CNS Therapeutics Market Share by Players in 2020 Figure 18. Global Top CNS Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CNS Therapeutics as of 2020 Figure 19. The Top 10 and 5 Players Market Share by CNS Therapeutics Revenue in 2020 Figure 20. Global CNS Therapeutics Revenue Market Share by Type (2016-2021) Figure 21. Global CNS Therapeutics Revenue Market Share by Type (2022-2027) Figure 22. North America CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. North America CNS Therapeutics Market Share by Type (2016-2027) Figure 24. North America CNS Therapeutics Market Share by Application (2016-2027) Figure 25. North America CNS Therapeutics Market Share by Country (2016-2027) Figure 26. United States CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Canada CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe CNS Therapeutics Market Share by Type (2016-2027) Figure 30. Europe CNS Therapeutics Market Share by Application (2016-2027) Figure 31. Europe CNS Therapeutics Market Share by Country (2016-2027) Figure 32. Germany CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. France CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. U.K. CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Italy CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Russia CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Nordic CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific CNS Therapeutics Market Share by Type (2016-2027) Figure 40. Asia-Pacific CNS Therapeutics Market Share by Application (2016-2027) Figure 41. Asia-Pacific CNS Therapeutics Market Share by Region (2016-2027) Figure 42. China CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Japan CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. South Korea CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Southeast Asia CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. India CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Australia CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America CNS Therapeutics Market Share by Type (2016-2027) Figure 50. Latin America CNS Therapeutics Market Share by Application (2016-2027) Figure 51. Latin America CNS Therapeutics Market Share by Country (2016-2027) Figure 52. Mexico CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Brazil CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa CNS Therapeutics Market Share by Type (2016-2027) Figure 56. Middle East & Africa CNS Therapeutics Market Share by Application (2016-2027) Figure 57. Middle East & Africa CNS Therapeutics Market Share by Country (2016-2027) Figure 58. Turkey CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Saudi Arabia CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. UAE CNS Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Pfizer Revenue Growth Rate in CNS Therapeutics Business (2016-2021) Figure 62. Janssen Pharmaceuticals Revenue Growth Rate in CNS Therapeutics Business (2016-2021) Figure 63. Allergan Revenue Growth Rate in CNS Therapeutics Business (2016-2021) Figure 64. Lundbeck Revenue Growth Rate in CNS Therapeutics Business (2016-2021) Figure 65. Teva Revenue Growth Rate in CNS Therapeutics Business (2016-2021) Figure 66. Camber Pharmaceuticals Revenue Growth Rate in CNS Therapeutics Business (2016-2021) Figure 67. Zhejiang Haisen Pharmaceutical Revenue Growth Rate in CNS Therapeutics Business (2016-2021) Figure 68. Jewim Pharmaceutical Revenue Growth Rate in CNS Therapeutics Business (2016-2021) Figure 69. Cipla Revenue Growth Rate in CNS Therapeutics Business (2016-2021) Figure 70. Merck Sharp & Dohme Corp. Revenue Growth Rate in CNS Therapeutics Business (2016-2021) Figure 71. Eli Lilly Revenue Growth Rate in CNS Therapeutics Business (2016-2021) Figure 72. GlaxoSmithKline Revenue Growth Rate in CNS Therapeutics Business (2016-2021) Figure 73. Novartis Revenue Growth Rate in CNS Therapeutics Business (2016-2021) Figure 74. LUPIN Revenue Growth Rate in CNS Therapeutics Business (2016-2021) Figure 75. ZYDUS PHARMS Revenue Growth Rate in CNS Therapeutics Business (2016-2021) Figure 76. Biogen Revenue Growth Rate in CNS Therapeutics Business (2016-2021) Figure 77. Otsuka Pharmaceutical Revenue Growth Rate in CNS Therapeutics Business (2016-2021) Figure 78. Astra Zeneca Revenue Growth Rate in CNS Therapeutics Business (2016-2021) Figure 79. Takeda Revenue Growth Rate in CNS Therapeutics Business (2016-2021) Figure 80. Bottom-up and Top-down Approaches for This Report Figure 81. Data Triangulation Figure 82. Key Executives Interviewed

Pfizer Janssen Pharmaceuticals Allergan Lundbeck Teva Camber Pharmaceuticals Zhejiang Haisen Pharmaceutical Jewim Pharmaceutical Cipla Merck Sharp & Dohme Corp. Eli Lilly GlaxoSmithKline Novartis LUPIN ZYDUS PHARMS Biogen Otsuka Pharmaceutical Astra Zeneca Takeda